bioRxivPathology
De novo identification of toxicants that cause irreparable damage to parasitic nematode intestinal cells
D. P. Jasmer, B. A. Rosa, R. Tyagi, C. A. Bulman, B. Beerntsen, J. F. Urban, J. Sakanari, M. Mitreva
Abstract
Efforts to identify new drugs for therapeutic and preventive treatments against parasitic nematodes have gained increasing interest with expanding pathogen omics databases and drug databases from which new anthelmintic compounds might be identified. Here, a novel approach focused on integrating a pan-Nematoda multi-omics data targeted to a specific nematode organ system (the intestinal tract) with evidence-based filtering and chemogenomic screening was undertaken. Based on de novo computational target prioritization of the 3,564 conserved intestine genes in A. suum, exocytosis was identified as a high priority pathway, and predicted inhibitors of exocytosis were tested using the large roundworm (Ascaris suum larval stages), a filarial worm (Brugia pahangi adult and L3), a whipworm (Trichuris muris adult), and the non-parasitic nematode Caenorhabditis elegans. 10 of 13 inhibitors were found to cause rapid immotility in A. suum L3 larvae, and five inhibitors were effective against the three phylogenetically diverse parasitic nematode species, indicating potential for a broad spectrum anthelmintics. Several distinct pathologic phenotypes were resolved related to molting, motility, or intestinal cell and tissue damage using conventional and novel histologic methods. Pathologic profiles characteristic for each inhibitor will guide future research to uncover mechanisms of the anthelmintic effects and improve on drug designs. This progress firmly validates the focus on intestinal cell biology as a useful resource to develop novel anthelmintic strategies. Author summaryThe intestinal cells of parasitic nematodes are not known to regenerate, therefore disruption of essential processes that cause irreparable damage to intestinal cells is expected to promote worm expulsion. To facilitate improved methods of therapy we need to better understand the basic intestinal cell and tissue functions of this critical organ. To that end have undertaken a comprehensive analysis of multi-omics omics data and identify and prioritize intestinal genes/pathways with essential functions and associated drugs and established a foundational model of the STH intestinal system using the large roundworm Ascaris suum to test and validate inhibitors of these functions. We found 10 inhibitors to impacted motility, and seven of those showed severe pathology and an apparent irreparable damage to intestinal cells. Furthermore, five inhibitors were effective against the three phylogenetically diverse parasitic nematode species, indicating potential for a broad spectrum anthelmintics. Our results firmly validate the focus on intestinal cell biology as a useful resource to develop novel anthelmintic strategies.
- organism: non-human primate
- assay: bulk RNA-seq
- research focus: drug response / drug discovery
- approach: deep learning
- approach: statistical model
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- An automated high-throughput system for phenotypic screening of chemical libraries on C. elegans and parasitic nematodes
F. A. Partridge, A. E. Brown, … D. B. Sattelle·bioRxiv·Sep 11, 2017
- Discovery of anthelmintic small molecules in the Medicines for Malaria Ventures COVID and Global Health Priority Boxes using an infrared-based assay for Caenorhabditis elegans motility
C. Caffrey, L. Liu, Y. U. Sun·bioRxiv·Dec 9, 2023
- Screening the Medicines for Malaria Pandemic Response Box chemical library on Caenorhabditis elegans identifies re-profiled candidate anthelmintic drug leads
M. Nick, F. A. Partridge, … D. B. Sattelle·bioRxiv·Aug 10, 2022
- In silico and in vitro Investigations of Antihelmintic Activities of some Selected Approved Drugs
A. C. Agube, D. L. Ajaghaku, I. C. Uzochukwu·Archives of Community Medicine and Public HealthPeer-reviewed·Nov 27, 2020
- Unveiling mode of action of anthelmintics in Caenorhabditis elegans with SydLab™, an on-a-chip automated and high-content screening system.
Thomas B. Duguet, Coralie Belgrano, … Lucien Rufener·bioRxiv·May 15, 2025
- High-throughput screening of more than 30,000 compounds for anthelmintics against gastrointestinal nematode parasites
Mostafa A. Elfawal, Emily M. Goetz, … Raffi V. Aroian·ACS Infectious DiseasesPeer-reviewed·Dec 9, 2024